Laurion Capital Management’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History

Laurion Capital Management’s Portfolio LKFT Stock Details LKFT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-2,018	Closed	-$395K	–	999
2020 Q1	$395K	Buy	+2,018	New	+$434K	﹤0.01%	609
2019 Q3	–	Sell	-3,806	Closed	-$491K	–	1124
2019 Q2	$491K	Buy	+3,806	New	+$452K	﹤0.01%	701
2019 Q1	–	Sell	-34,168	Closed	-$3.13M	–	1010
2018 Q4	$3.13M	Sell	34,168 -142,308	-81%	-$14.4M	0.06%	372
2018 Q3	$19.8M	Buy	+176,476	New	+$18.6M	0.19%	112

Other funds holding LKFT

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Bessemer Group Woodbridge, New Jersey $63.6B AUM 28.76% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

Laurion Capital Management's LKFT Position: Q2 2020 in Review

Laurion Capital Management sold out of Lakefront Biotherapeutics American Depositary Shares (LKFT) in Q2 2020, closing a stake of 2,018 shares — an estimated $395K sold.

Laurion Capital Management first reported a position in LKFT in Q3 2018 and held it in 4 quarters. The position peaked at $19.8M in Q3 2018. 143 funds tracked by Wall St. Rank hold LKFT as of Q2 2020.

Laurion Capital Management reported no remaining Lakefront Biotherapeutics American Depositary Shares position as of Q2 2020 after selling out during the quarter.
Laurion Capital Management sold 2,018 Lakefront Biotherapeutics American Depositary Shares shares in Q2 2020, an estimated $395K.
Laurion Capital Management first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q3 2018 and held it in 4 quarters.
Laurion Capital Management's Lakefront Biotherapeutics American Depositary Shares position peaked at $19.8M in Q3 2018.
143 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q2 2020.

Based on Laurion Capital Management's 13F filing for Q2 2020, filed 14 Aug 2020.